Last updated 2026-06-18
- Raised funding round led by NGT HealthCare II, Jan 2023
Total raised
—
Last: 2023-01
Stage
Pre-Seed
Founded
2023
Headcount
6
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
Noxon develops a novel drug for oral treatment of fibrotic lung diseases. The developed drug, 3-cabamoyl-proxyl, is a stable organic radical belonging to the nitroxides group.
Its product, 3-CP, which has a unique antioxidant property, has been shown to reduce airway inflammation, airway hyper-responsiveness, and other inflammatory mediators of the lung tissues, as seen in animal models of allergic asthma.
Funding history · 1 round · — total
2023-01
Undisclosed
Q&A
- What is Noxon's primary focus?
- Noxon is focused on drug development for fibrotic lung diseases.
- When was Noxon founded?
- Noxon was founded in January 2023.
- What is Noxon's main product?
- Noxon's main product is 3-CP, a novel drug for oral treatment of fibrotic lung diseases, which has shown to reduce airway inflammation and hyper-responsiveness in animal models of allergic asthma.
- What is Noxon's current funding stage?
- Noxon is currently in the Pre-Seed funding stage.
- Which investor participated in Noxon's January 2023 funding round?
- NGT HealthCare II participated in Noxon's funding round in January 2023.
- What is Noxon's primary sector?
- Noxon's primary sector is Health Tech & Life Sciences.
- Where is Noxon headquartered?
- Noxon is headquartered in Nazareth, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2C
Tags
pharmaceuticalsdrug-discoveryhealthcareoral-drugs
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ngt-healthcare2.com/noxon/ |
|---|
Identifiers & details
| Founded | 2023-1 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 108 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | ngt-healthcare2.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|